Branded Generic vs. Authorized Generic: Which Strategy Offers Higher ROI at the Patent Cliff
Patent cliff ROI isnt just a legal questionits a packaging problem.
If youre advising pharma, MSLs, payer contracting teams, or growth strategy leaders, the brand vs. generic debate is familiar. But the real ROI swing at the patent cliff often lives …
